Danaher Corporation $DHR Holdings Cut by World Investment Advisors

World Investment Advisors lowered its holdings in Danaher Corporation (NYSE:DHR) by 10.3% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,246 shares of the conglomerate’s stock after selling 1,633 shares during the period. World Investment Advisors’ holdings in Danaher were worth $2,814,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of DHR. Pacific Capital Partners Ltd bought a new position in Danaher in the first quarter worth about $7,175,000. Koshinski Asset Management Inc. lifted its holdings in Danaher by 18.2% in the first quarter. Koshinski Asset Management Inc. now owns 1,738 shares of the conglomerate’s stock worth $356,000 after acquiring an additional 267 shares during the last quarter. Clear Creek Financial Management LLC bought a new stake in shares of Danaher during the first quarter valued at approximately $262,000. First Horizon Advisors Inc. raised its holdings in shares of Danaher by 7.7% during the first quarter. First Horizon Advisors Inc. now owns 5,294 shares of the conglomerate’s stock valued at $1,085,000 after buying an additional 380 shares during the last quarter. Finally, Resonant Capital Advisors LLC raised its holdings in shares of Danaher by 2.5% during the first quarter. Resonant Capital Advisors LLC now owns 13,994 shares of the conglomerate’s stock valued at $2,873,000 after buying an additional 342 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.4%

DHR opened at $214.97 on Friday. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The stock’s fifty day moving average is $203.33 and its 200-day moving average is $199.31. The company has a market capitalization of $151.84 billion, a PE ratio of 44.32, a P/E/G ratio of 3.28 and a beta of 0.77.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the business earned $1.71 EPS. The company’s quarterly revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is 26.39%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on DHR shares. Cowen reaffirmed a “buy” rating on shares of Danaher in a report on Wednesday, October 22nd. Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Barclays raised their price target on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Royal Bank Of Canada set a $241.00 price target on Danaher in a report on Tuesday, September 2nd. Finally, JPMorgan Chase & Co. raised their price target on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.